Rheological characterization and drug release studies of gum exudates of terminalia catappa linn

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 885-890

  Kumar, Sadhis V ^a   Sasmal, Dinakar ^a   Pal, Subodh C ^b  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

^b Department of Pharmacognosy   (India)

Author keywords

Controlled release; Dextromethorphan hydrobromide; Gum exudates of Terminalia catappa; Viscosity

Indexed keywords

DEXTROMETHORPHAN; EXCIPIENT; TERMINALIA CATAPPA GUM; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG GRANULATION; DRUG SOLUBILITY; FLOW KINETICS; PH; SUSTAINED DRUG RELEASE; TABLET; TERMINALIA; TERMINALIA CATAPPA; VISCOSITY;

DELAYED-ACTION PREPARATIONS; DEXTROMETHORPHAN; HYDROGEN-ION CONCENTRATION; PLANT GUMS; RHEOLOGY; TABLETS; TERMINALIA; VISCOSITY;

EID: 57149145204     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9101-5     Document Type: Article

References (25)

1. T. R. Bhardwaj, M. Kanwar, R. Lal, and A. Gupta. Natural gums and modified natural gums as sustained release carriers. Drug Dev Ind Pharm. 26(10):1025-1038 (2000).
2. M. M. Talukdar, A. Michoel, P. Rombaut, and R. Kinget. Comparative study on xanthan gum and hydroxypropylmethylcellulose as matrices for controlled-release drug delivery. I. Compaction and in vitro drug release behavior. Int J Pharm. 129:233-241 (1996).
3. S. Chirico, A. Dalmoro, G. Lamberti, G. Russo, and G. Titomanlio. Analysis and modeling of swelling and erosion behavior for pure HPMC tablet. J Control Rel. 122:181-188 (2007).
4. J. Mulhbacher, P. Ispas-Szabo, and M. A. Mateescu. Cross-linked high amylose starch derivatives for drug release II. Swelling properties and mechanistic study. Int J Pharm. 278:231-238 (2004).
5. H. Onishi, T. Oosegi, Y. Machida, and J. W. McGinity. Eudragit coating of chitosan-prednisolone conjugate microsphere and in vitro evaluation of coated microspheres. Drug Dev Ind Pharm. 33:848-854 (2007).
6. N. Wu, L. Wang, D. C. Tan, S. M. Moochhala, and Y. Yang. Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: Polyethylene oxide with high molecular weights. J Control Rel. 102:569-581 (2005).
7. D. F. Durso. Handbook of water soluble gums and resins, 1st ed., McGraw Hill, New York, NY, 1980, p. 12.
8. M. Nakano, Y. Nakamura, K. Takikawa, M. Kouketsu, and T. Arita. Sustained release of sulphamethizole from agar beads. J Pharm Pharmacol. 31(12):869-872 (1979).
9. S. Altaf, K. Yu, J. Parasrampuria, and D. R. Friend. Guar gum-based sustained release diltiazem. Pharm Res. 15:1196-1201 (1998).
10. S. A. Agnihotri, S. S. Jawalkar, and T. M. Aminabhavi. Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size and drug release. Eur J Pharm Biopharm. 63:249-261 (2006).
11. T. C. Lin. Study on the tannins and related compounds in the fruit of Terminalia catappa L. J Chi Med Pharm Res. 14:165-174 (1992).
12. P. S. Chen, J. H. Li, T. Y. Liu, and T. C. Lin. Folk medicine Terminalia catappa and its major tannin component, punicalagin, are effective against bleomycin-induced genotoxicity in Chinese hamster ovary cells. Cancer Lett. 152:115-122 (2000).
13. A. N. Nagappa, P. A. Thakurdesai, N. Venkatrao, and S. Jiwan. Antidiabetic activity of Terminalia catappa L, fruits. J Ethnopharmacol. 88(1):45-50 (2003).
14. T. Tanaka, G. I. Nonaka, and I. Nishioka. Tannins and related compounds. XLII. Isolation and characterization of four new hydrolysable tannins, terflavins A and B, ergallagin and tercatain from leaves of Terminalia catappa L. Chem Pharm Bull. 34:1039-1049 (1986).
15. J. T. A. Oliveira, I. M. Vasconcelos, L. C. N. M. Bezerra, S. B. Silveira, A. C. O. Monteiro, and R. A. Moreira. Composition and nutritional properties of seeds from Pachira aquatica Aubl, Sterculia striata St Hil et Naud and Terminalia catappa Linn. Food Chem. 70:185-191 (2000).
16. W. Dorsch, and H. Wagner. New antiasthmatic drugs from traditional medicine. Int. Arch Aller Appl Immun. 94:262-265 (1991).
17. A. R. Ray, V. Batra, A. Bhowmick, and B. K. Behra. Sustained release of ferrous sulfate from polymer-coated gum arabica pellets. J Pharm Sci. 83:632-635 (1994).
18. D. L. Munday, and P. J. Cox. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms. Int J Pharm. 203(1-2):179-192 (2000).
19. B. Daniel. Controlled release composition, U.S. Patent No. 6787156, 2004.
20. G. Bonacucina, S. Martelli, and G. F. Palmieri. Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents. Int J Pharm. 282:115-130 (2004).
21. A. Allahham, P. Stewart, J. Marriott, and D. Mainwaring. Factors affecting shear thickening behavior of a concentrated injectable suspension of levodopa. J Pharm Sci. 94(11):2393-2402 (2005).
22. N. A. Peppas. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 60:110-111 (1985).
23. M. S. Reza, M. A. Quadir, and S. S. Haider. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J Pharm Pharmaceut Sci. 6(2):282-291 (2003).
24. P. L. Ritger, and N. A. Peppas. A Simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Rel. 5:23-36 (1987).
25. P. L. Ritger, and N. A. Peppas. A Simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Rel. 5:37-42 (1987).